Values as of: 2024-11-16
COMMON STOCK | Specialty Chemicals |
Last Closing
USD 108.89Change
0.00 (0.00)%Market Cap
USD 18.31BVolume
118.00Analyst Target
N/AVerdict
Verdict
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates through two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for fish feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, aroma molecules, cosmetic ingredients, and mint flavors, as well as specific application processes for such substances. This segment's products are used by manufacturers of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.
Company Website : https://www.symrise.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| AIQUF | L'Air Liquide S.A |
N/A |
USD 103.59B |
| AIQUY | Air Liquide SA ADR |
N/A |
USD 103.45B |
| GVDBF | Givaudan SA |
N/A |
USD 48.08B |
| SKFOF | Sika AG |
N/A |
USD 45.12B |
| SXYAY | Sika AG ADR |
N/A |
USD 45.12B |
| GVDNY | Givaudan SA ADR |
N/A |
USD 44.15B |
| DSMFF | DSM-Firmenich AG |
N/A |
USD 32.60B |
| NVZMF | Novozymes A/S B |
N/A |
USD 29.53B |
| NPPHY | Nippon Paint Holdings Co. Ltd. |
N/A |
USD 19.82B |
| EMSHF | EMS-CHEMIE HOLDING AG |
N/A |
USD 18.32B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| XS8R:LSE | Xtrackers MSCI Europe Inf.. | 0.00 % | 0.00 % |
N/A |
USD 0.04B |
| IS3H:XETRA | iShares MSCI EMU Mid Cap .. | 0.00 % | 0.00 % |
N/A |
USD 0.13B |
| BECO | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Specialty Chemicals) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 0.04% | 65% | D | 53% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 0.04% | 65% | D | 52% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | 4.10% | 63% | D | 54% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 4.10% | 63% | D | 53% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 11.80% | 76% | C+ | 67% | D+ | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | 11.80% | 76% | C+ | 66% | D+ | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 2.67% | 43% | F | 42% | F | ||
| Dividend Return | 3.47% | 39% | F | 40% | F | ||
| Total Return | 0.80% | 16% | F | 21% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 18.31% | 90% | A- | 89% | A- | ||
| Risk Adjusted Return | 18.96% | 56% | F | 53% | F | ||
| Market Capitalization | 18.31B | 88% | B+ | 94% | A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
